ista pharmaceuticals inc. Resources | BNET
On GameSpot: Wii Fit tells 10-year-old she's fat

BNET Industries

Ista Pharmaceuticals Inc.

is in the Pharma Industry

Filter by Source:

ista pharmaceuticals inc. - All News and Analysis

Additional Resources

  • ISTA Pharmaceuticals Increases Credit Facility with Silicon Valley Bank

    - 2008-12-24

    IRVINE, Calif., Dec. 24 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. , today announced it has increased the maximum the Company can borrow on its existing revolving line of credit with Silicon Valley Bank to $25 million from $10 million. Under the new credit line, ISTA can borrow an amount...

  • Celera Elects Wayne I. Roe to Board of Directors

    - 2008-12-08

    ALAMEDA, Calif. -- Celera Corporation (NASDAQ:CRA) today announced the election of Wayne I. Roe as a Director of the company. Mr. Roe has been a general partner of DFJ In-Cube Ventures, an early stage medical technology fund, since 2007. He currently sits on the boards of directors of ISTA Pharmaceuticals,...

  • ISTA Pharmaceuticals to Participate at the RBC Capital Markets Healthcare Conference

    - 2008-12-05

    IRVINE, Calif., Dec. 5 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. , today announced Lauren Silvernail, CFO and Vice President of Corporate Development, will participate in a panel discussion on "Adapting Specialty Pharma Strategy to Market Conditions" at the RBC Capital Markets Healthcare Conference. The panel will begin at 10:00 a.m....

  • ISTA Pharmaceuticals Announces Phase III Results for Once-Daily Topical Xibrom™ 0.09%

    - 2008-12-04

    IRVINE, Calif., Dec. 4 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. , an ophthalmic pharmaceutical company, today announced results from the Company's recently completed Phase III clinical program of XibromTM (0.09% bromfenac sodium ophthalmic solution) QD (once-daily). The program enrolled 282 patients who underwent cataract surgery in two U.S. multi-center,...

  • ISTA Pharmaceuticals Files New Drug Application with U.S. FDA for Bepreve™

    - 2008-11-13

    IRVINE, Calif., Nov. 13 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. , today announced the Company filed a New Drug Application NDA with the U.S. Food and Drug Administration FDA for BepreveTM bepotastine ophthalmic solution. The Company is seeking approval for Bepreve as an eye drop treatment for ocular itching associated...

  • ISTA Pharmaceuticals Reports Third Quarter 2008 Financial Results

    - 2008-10-30

    - Reaffirms 2008 Revenue Guidance of $75 to $82 million - IRVINE, Calif., Oct. 30 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. , an ophthalmic pharmaceutical company, today reported financial results for the third quarter ended September 30, 2008. ISTA reported net revenue for the three months...

  • ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2008 Financial Results

    - 2008-10-24

    IRVINE, Calif., Oct. 24 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. , today announced it will release third quarter 2008 financial results on October 30, 2008, and will host a conference call to discuss these results and provide a pipeline update at 10:00 a.m. Eastern Time. Date: Thursday, October...

  • Ista Pharmaceuticals Inc. Tops Deloitte's Orange County Technology Fast 50 Ranking of Fastest Growing Companies, With 21075.18 Percent Revenue Growth Over Five Years

    - 2008-10-24

    Orange County Technology Fast 50 Companies Experience Average Revenue Growth of 1629.59 Percent COSTA MESA, Calif., Oct. 23 /PRNewswire/ -- ISTA Pharmaceuticals, Inc. tops the list of the fastest growing companies in Orange County as recognized by Deloitte LLP at an award event held October 23 at...

  • ISTA Pharmaceuticals to Present at the Seventh Annual BIO Investor Forum

    - 2008-10-24

    IRVINE, Calif., Oct. 24 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. , today announced it will present at the Seventh Annual BIO Investor Forum at 9:00 a.m. Pacific Time on Friday, October 31, 2008, at the Palace Hotel in San Francisco, CA. ISTA's CFO and Vice President of Corporate...

  • Ista Gets Financing, Banking on Drugs in Development

    - 2008-10-06

    Device Maker ICU Lands Deal With Hospital Buying Group; Peregrine Gets Nasdaq Reprieve HEALTHCARE Ista Pharmaceuticals Inc., an Irvine drug maker, has struck a financing deal and is hopeful three key products could get regulatory approval within the next 12 to 18 months. Late last...

  • NEWS: Update

    - 2008-05-01

    The Direct Marketing Association projected that pharma sales through direct marketing will reach $10.6 billion this year and rise to $15.2 billion in 2012. Pharma, the trade group said, will spend more than $1 billion on direct this year, and will realize an ROI of $10.27 for every dollar spent....

  • Economy Could Prompt More Small Drug Co. Buyouts

    - 2008-04-28

    The tough economy could open up deal opportunities for some of Orange County's smaller drug and device companies. There's already been movement on that front, according to market watchers. Earlier this month, Irvine eye drug maker Ista Pharmaceutical s Inc. hired Cowen & Co. to evaluate opportunities that could...

  • Ista Readying to Start Trial of Nasal Allergy Treatment

    - 2008-03-31

    HEALTHCARE Analyst: I-Flow Nears 'Permanent Profitability'; Consumer-Directed Health Plans Show Gains Ista Pharmaceuticals Inc., an Irvine drug developer, is known for eye treatments. Now it's moving toward fighting nasal allergies. Ista soon plans to start clinical trials for a nasal formulation of bepotastine, a...

  • BellwetherReport.com Free Analyst Review for ISTA.

    - 2008-03-20

    M2 PRESSWIRE-20 March 2008-Bellwether Interviews: BellwetherReport.com Free Analyst Review for ISTAC1994-2008 M2 COMMUNICATIONS LTD RDATE:20032008 BellwetherReport.com is the leading online financial newsletter for investors seeking top independent and unbiased research. Investors seeking free and unbiased research on the...

  • Drug Withdrawal

    - 2008-03-17

    Ista Pharmaceuticals Slumps on Regulatory Setbacks for New Drugs The chief executive of Ista Pharmaceuticals Inc. thinks Wall Street can be swayed, despite a loss of more than half of the drug maker's market value earlier this month on regulatory setbacks. Vince Anido is pinning his...

  • ISTA Pharmaceuticals, Inc. Review in Progress.

    - 2008-02-22

    M2 PRESSWIRE-22 February 2008-Market Review: ISTA Pharmaceuticals, Inc. Review in ProgressC1994-2008 M2 COMMUNICATIONS LTD RDATE:22022008 Streetinvesting.com has now resumed our progressive review of ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) after it traded down 2% Friday, late in the morning with...

  • Has added ISTA Pharmaceuticals Inc. to their watch list.

    - 2008-02-22

    M2 PRESSWIRE-22 February 2008-The Maybach Journal: Has added ISTA Pharmaceuticals Inc. to their watch listC1994-2008 M2 COMMUNICATIONS LTD RDATE:22022008 Maybach Financial is a syndicate of financial informants representing a true investing experience. Taking research from financial consultants, brokers,...

Sort byClose

View by Content TypeClose